Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The hepatitis delta virus: Replication and pathogenesis
Camille Sureau, Francesco Negro
Journal of Hepatology (2016) Vol. 64, Iss. 1, pp. S102-S116
Open Access | Times Cited: 243

Showing 1-25 of 243 citing articles:

Hepatitis C virus infection
Michael P. Manns, Marı́a Buti, Ed Gane, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 431
A 360° view of circular RNAs: From biogenesis to functions
Jeremy E. Wilusz
Wiley Interdisciplinary Reviews - RNA (2018) Vol. 9, Iss. 4
Open Access | Times Cited: 393
Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
Haiyan Chen, Danting Shen, Dong‐Ze Ji, et al.
Gut (2018) Vol. 68, Iss. 3, pp. 512-521
Closed Access | Times Cited: 335
Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
Zhijiang Miao, Shaoshi Zhang, Xumin Ou, et al.
The Journal of Infectious Diseases (2019) Vol. 221, Iss. 10, pp. 1677-1687
Open Access | Times Cited: 273
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Simmone D’souza, Keith C.K. Lau, Carla S. Coffin, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 38, pp. 5759-5783
Open Access | Times Cited: 187
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer, Cihan Yurdaydın, Svenja Hardtke, et al.
The Lancet Infectious Diseases (2019) Vol. 19, Iss. 3, pp. 275-286
Closed Access | Times Cited: 160
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. 117-129
Closed Access | Times Cited: 98
Mining metatranscriptomes reveals a vast world of viroid-like circular RNAs
Benjamin D. Lee, Uri Neri, Simon Roux, et al.
Cell (2023) Vol. 186, Iss. 3, pp. 646-661.e4
Open Access | Times Cited: 64
Viral hepatitis and hepatocellular carcinoma: etiology and management
Philippe J. Zamor, Andrew S. deLemos, Mark W. Russo
Journal of Gastrointestinal Oncology (2017) Vol. 8, Iss. 2, pp. 229-242
Open Access | Times Cited: 138
Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
Dulce Alfaiate, Sophie Clément, Diana Gomes, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 533-539
Closed Access | Times Cited: 137
Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
Jimena Pérez‐Vargas, Fouzia Amirache, Bertrand Boson, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 126
Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis
Alexander Stockdale, Mas Chaponda, Apostolos Beloukas, et al.
The Lancet Global Health (2017) Vol. 5, Iss. 10, pp. e992-e1003
Open Access | Times Cited: 120
Hepatitis delta: virological and clinical aspects
Luan Felipo Botelho Souza, Mariana Pinheiro Alves Vasconcelos, Alcione de Oliveira dos Santos, et al.
Virology Journal (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 116
Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes
Zhenfeng Zhang, Christina Filzmayer, Yi Ni, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 1, pp. 25-35
Closed Access | Times Cited: 115
A review on hepatitis D: From virology to new therapies
Nathalie Mentha, Sophie Clément, Francesco Negro, et al.
Journal of Advanced Research (2019) Vol. 17, pp. 3-15
Open Access | Times Cited: 104
Antiviral treatment and liver‐related complications in hepatitis delta
A. Wranke, Beatriz Calle Serrano, Benjamin Heidrich, et al.
Hepatology (2016) Vol. 65, Iss. 2, pp. 414-425
Closed Access | Times Cited: 103
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
Cihan Yurdaydın, Zaigham Abbas, Marı́a Buti, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 5, pp. 1008-1015
Open Access | Times Cited: 100
Pathogenesis of and New Therapies for Hepatitis D
Christopher Koh, Theo Heller, Jeffrey S. Glenn
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 461-476.e1
Open Access | Times Cited: 98
The Baltimore Classification of Viruses 50 Years Later: How Does It Stand in the Light of Virus Evolution?
Eugene V. Koonin, Mart Krupovìč, Vadim I. Agol
Microbiology and Molecular Biology Reviews (2021) Vol. 85, Iss. 3
Open Access | Times Cited: 91
Emerging Microbes & Infections
Kwok‐Yung Yuen
(2016)
Closed Access | Times Cited: 90
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, et al.
Zeitschrift für Gastroenterologie (2021) Vol. 59, Iss. 07, pp. 691-776
Open Access | Times Cited: 73
Current situation of viral hepatitis in Egypt
Ashraf Elbahrawy, Marwa K. Ibrahim, Ahmed Eliwa, et al.
Microbiology and Immunology (2021) Vol. 65, Iss. 9, pp. 352-372
Open Access | Times Cited: 62
Hepatitis D
Francesco Negro, Anna S. Lok
JAMA (2023) Vol. 330, Iss. 24, pp. 2376-2376
Closed Access | Times Cited: 41
Diagnosis and Management of Hepatitis Delta Virus Infection
Calvin Pan, Robert G. Gish, Ira M. Jacobson, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 8, pp. 3237-3248
Open Access | Times Cited: 23
Hepatitis Delta Virus and Hepatocellular Carcinoma
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top